MedPath

A study to test accuracy of FMRA software in comparison with MRI scan for measuring uterine fibroids.

Not Applicable
Completed
Conditions
Health Condition 1: D251- Intramural leiomyoma of uterus
Registration Number
CTRI/2021/12/038601
Lead Sponsor
esa Medtech Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

1. Women aged 18 to 60, diagnosed with lesser than 3 fibroids, and maximum fibroid size being 5cm

2. Women willing to undergo Transvaginal ultrasound and MRI of Pelvis

3. Women willing to provide consent for participation in this investigation.

Exclusion Criteria

1. Unmarried women

2. Women with Type 0,1,6,7 fibroids as per FIGO classification

3. Women in whom TVS cannot be done due to severe vaginismus/ vaginal stenosis

4. Women who are pregnant

5. Women with endometrial polyps

6. Women with uterus size of >15cm

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the accuracy of size, coordinates of fibroids and uterus dimensions generated by FMRA software w.r.t values interpolated from MRI images.Timepoint: At baseline only
Secondary Outcome Measures
NameTimeMethod
To assess the time required for annotation in FMRA to generate the 3D rendered representation of the uterus model.Timepoint: At baseline only
© Copyright 2025. All Rights Reserved by MedPath